April 13, 2018
A New Orleans startup with Baton Rouge ties announced this morning the launch of a new prebiotic dietary supplement that helps curb hunger, manage blood sugar levels and promote overall GI health.
BiomeBliss is the product of New Orleans-based Biome Therapeutics, which is co-owned by nationally renowned obesity expert Mark Heiman and company CEO Dale Pfost, a biotechnology entrepreneur.
Heiman was educated at LSU in the late 1970s, before going on to become chief scientific officer for obesity research at Eli Lilly Research Labs. He has spent the past decade developing BiomeBliss, which was tested in two clinical trials in 2015 at Pennington Biomedical Research Center.
Click here to read the full story from Baton Rouge Business Report.